Purchases and Sales Made in Q3 2023 in Black Diamond Therapeutics, Inc. (BDTX)
This table provides information about the institutional ownership of Black Diamond Therapeutics, Inc. (BDTX) during Q3 2023. The information is specifically focused on institutions that hold shares of Black Diamond Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-870K- 48.31% |
$2.5M - $4.34M
|
930K
$2.03M
|
|
|
Nov 14, 2023
Q3 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-885K- 44.25% |
$2.54M - $4.42M
|
1.12M
$2.43M
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.2M- 98.46% |
$3.43M - $5.97M
|
18.8K
$40.9K
|